1. Home
  2. ICUI vs TSEM Comparison

ICUI vs TSEM Comparison

Compare ICUI & TSEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • TSEM
  • Stock Information
  • Founded
  • ICUI 1984
  • TSEM 1993
  • Country
  • ICUI United States
  • TSEM Israel
  • Employees
  • ICUI N/A
  • TSEM N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • TSEM Semiconductors
  • Sector
  • ICUI Health Care
  • TSEM Technology
  • Exchange
  • ICUI Nasdaq
  • TSEM Nasdaq
  • Market Cap
  • ICUI 3.5B
  • TSEM 4.0B
  • IPO Year
  • ICUI 1992
  • TSEM 1994
  • Fundamental
  • Price
  • ICUI $142.87
  • TSEM $37.49
  • Analyst Decision
  • ICUI Buy
  • TSEM Strong Buy
  • Analyst Count
  • ICUI 5
  • TSEM 3
  • Target Price
  • ICUI $197.50
  • TSEM $60.00
  • AVG Volume (30 Days)
  • ICUI 269.6K
  • TSEM 484.6K
  • Earning Date
  • ICUI 05-08-2025
  • TSEM 05-14-2025
  • Dividend Yield
  • ICUI N/A
  • TSEM N/A
  • EPS Growth
  • ICUI N/A
  • TSEM N/A
  • EPS
  • ICUI N/A
  • TSEM 1.85
  • Revenue
  • ICUI $2,382,046,000.00
  • TSEM $1,436,122,000.00
  • Revenue This Year
  • ICUI $0.84
  • TSEM $10.99
  • Revenue Next Year
  • ICUI $2.91
  • TSEM $11.17
  • P/E Ratio
  • ICUI N/A
  • TSEM $19.45
  • Revenue Growth
  • ICUI 5.44
  • TSEM 0.94
  • 52 Week Low
  • ICUI $95.44
  • TSEM $28.64
  • 52 Week High
  • ICUI $196.26
  • TSEM $55.31
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 54.65
  • TSEM 54.94
  • Support Level
  • ICUI $131.73
  • TSEM $35.42
  • Resistance Level
  • ICUI $142.00
  • TSEM $37.65
  • Average True Range (ATR)
  • ICUI 5.87
  • TSEM 1.00
  • MACD
  • ICUI 0.68
  • TSEM 0.29
  • Stochastic Oscillator
  • ICUI 89.16
  • TSEM 89.75

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About TSEM Tower Semiconductor Ltd.

Tower Semiconductor Ltd is a pure-play specialty foundry that manufactures semiconductors. As a pure-play foundry, it focuses on producing integrated circuits (ICs), based on the design specifications of customers. The company's line of integrated circuits is incorporated into a range of products and markets, including consumer electronics, personal computers, communications, automotive, and industrial and medical device products. Tower produces ICs alongside wholly-owned subsidiaries through fabrication facilities located in Japan. As a complement to its technology offerings, Tower offers services that enable a quick and accurate design cycle. To further assist customers with design and technical support, an integrated team helps clients through the manufacturing cycle.

Share on Social Networks: